Guanmou Li, Cheng Luo, Teng Ge, Kunyang He, Miao Zhang, Jinlin Hu, Baoshi Zheng, Rongjun Zou, Xiaoping Fan
{"title":"Evaluating the impact of metabolic indicators and scores on cardiovascular events using machine learning.","authors":"Guanmou Li, Cheng Luo, Teng Ge, Kunyang He, Miao Zhang, Jinlin Hu, Baoshi Zheng, Rongjun Zou, Xiaoping Fan","doi":"10.1186/s13098-025-01753-1","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular diseases such as coronary artery disease, myocardial infarction, and heart failure impact millions of people annually globally and are a major cause of disease and death. This study explores the predictive capabilities of novel metabolic indices (TyG, HOMA-IR, TG/HDL-C, and VAI) for major adverse cardiovascular events (MACE) and analyzes their relationships with diabetes and cardiovascular risks. Using data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2003 to 2018, we applied multiple machine learning algorithms to evaluate nine metabolic indicators including cholesterol levels, triglycerides, insulin, and waist circumference. Through cross-validation to validate model performance, the XGBoost algorithm demonstrated the most accurate performance in predicting cardiovascular outcomes, particularly for diseases like angina and heart failure. Additionally, SHAP value analysis confirmed the critical roles of waist circumference and METS-IR in predicting adverse cardiovascular events. Furthermore, we employed 100 machine learning algorithms to calculate the AUC values of metabolic indicators in predicting AP, CHD, HF, and MI, showing that METS-IR had the greatest contribution in these aspects. This research highlights the significance of metabolic indices in stratifying cardiovascular risks and presents potential avenues for targeted preventive strategies.</p>","PeriodicalId":11106,"journal":{"name":"Diabetology & Metabolic Syndrome","volume":"17 1","pages":"180"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123715/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology & Metabolic Syndrome","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13098-025-01753-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Cardiovascular diseases such as coronary artery disease, myocardial infarction, and heart failure impact millions of people annually globally and are a major cause of disease and death. This study explores the predictive capabilities of novel metabolic indices (TyG, HOMA-IR, TG/HDL-C, and VAI) for major adverse cardiovascular events (MACE) and analyzes their relationships with diabetes and cardiovascular risks. Using data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2003 to 2018, we applied multiple machine learning algorithms to evaluate nine metabolic indicators including cholesterol levels, triglycerides, insulin, and waist circumference. Through cross-validation to validate model performance, the XGBoost algorithm demonstrated the most accurate performance in predicting cardiovascular outcomes, particularly for diseases like angina and heart failure. Additionally, SHAP value analysis confirmed the critical roles of waist circumference and METS-IR in predicting adverse cardiovascular events. Furthermore, we employed 100 machine learning algorithms to calculate the AUC values of metabolic indicators in predicting AP, CHD, HF, and MI, showing that METS-IR had the greatest contribution in these aspects. This research highlights the significance of metabolic indices in stratifying cardiovascular risks and presents potential avenues for targeted preventive strategies.
期刊介绍:
Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.
By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.